Management of Sleep Maintenance Insomnia in a 55-Year-Old Male
Start with cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, specifically targeting the sleep maintenance component with sleep restriction and stimulus control techniques 1, 2.
Initial Diagnostic Considerations
Before initiating treatment, evaluate for:
- Sleep-disordered breathing (snoring, witnessed apneas, daytime sleepiness) - the frequent movement may indicate periodic limb movements or restless legs syndrome
- Medication review - substances affecting sleep architecture
- Psychiatric comorbidities - depression and anxiety commonly present with sleep maintenance problems
- Sleep diary for 1-2 weeks - documenting actual sleep patterns, movements, and awakenings 2
Consider polysomnography if treatment-resistant or if periodic limb movement disorder or sleep apnea is suspected, as these can cause frequent nocturnal movements and awakenings 3.
First-Line Treatment: CBT-I
The evidence strongly supports CBT-I over pharmacotherapy for chronic insomnia, particularly for sleep maintenance problems 1, 2. For this patient's specific presentation:
Key CBT-I components to emphasize:
- Sleep restriction therapy - limiting time in bed to actual sleep time, then gradually increasing as sleep efficiency improves (most effective for sleep maintenance insomnia)
- Stimulus control - strengthening bed-sleep association, leaving bed if awake >20 minutes
- Relaxation techniques - addressing hyperarousal that prevents sleep maintenance
CBT-I can be delivered face-to-face, via telehealth, or through digital platforms with similar efficacy 1. The behavioral components alone (BBT-I) are effective if full CBT-I is unavailable 2.
Important caveat: Sleep hygiene education alone is insufficient and should not be used as monotherapy - it showed no benefit compared to no treatment in head-to-head trials 1.
Pharmacotherapy (If CBT-I Insufficient)
Given the patient's age (55) and sleep maintenance problem, pharmacological options should be considered only after CBT-I trial or as adjunct 2, 3:
Preferred agents for sleep maintenance in this age group:
Dual orexin receptor antagonists (daridorexant, suvorexant, lemborexant) - specifically effective for sleep maintenance, can be used for 3+ months, minimal side effects 3, 4. This is the most appropriate pharmacologic choice for his specific complaint.
Low-dose doxepin (3-6 mg) - FDA-approved for sleep maintenance, safer profile in older adults 5, 4
Prolonged-release melatonin - can be used up to 3 months in patients ≥55 years 3
Agents to avoid:
Benzodiazepines and Z-drugs - should be limited to ≤4 weeks if used at all due to fall risk, cognitive impairment, and dependence potential 3. While guidelines acknowledge they can be used short-term 1, 2, the 2023 European guideline and recent literature emphasize avoiding them when possible 6, 3.
Antihistamines (diphenhydramine) - not recommended per guidelines despite common use 3
Antipsychotics - not recommended for insomnia 3
Addressing the Movement Component
The frequent nocturnal movement warrants specific attention:
- If periodic limb movements are confirmed, consider iron studies (ferritin <75 μg/L suggests treatment)
- Gabapentin or pregabalin may address both sleep maintenance and movement if periodic limb movement disorder is present
- This would require polysomnography for definitive diagnosis if symptoms persist despite insomnia treatment
Treatment Algorithm
- Weeks 1-2: Sleep diary, screen for sleep disorders
- Weeks 3-10: CBT-I (typically 4-8 sessions focusing on sleep restriction and stimulus control)
- If inadequate response: Add dual orexin receptor antagonist OR low-dose doxepin
- If movements persist: Consider polysomnography to evaluate for periodic limb movement disorder
The combination of CBT-I with pharmacotherapy is more effective than either alone when behavioral therapy is insufficient 2, but always start with CBT-I as it provides durable benefits without medication risks 1, 3.